在喘粘液生物学和新兴治疗策略的最新进展
Sergey Fedosenko1, Carmen Venegas Garrido, Parameswaran Nair
1Division of Respirology, Department of Medicine, St Joseph's Healthcare and McMaster University, Hamilton, Ontario, Canada.
Current opinion in pulmonary medicine
|March 6, 2025
概括
喘研究的最新进展揭示了关于粘液过分分泌的新见解,粘液过分分泌是呼吸道阻塞的关键因素. 针对粘液特性和炎症的新型疗法显示出改善严重喘患者肺功能的希望.
科学领域:
- 肺部医学 肺部医学
- 呼吸系统生理学 呼吸系统生理学
- 生物医学工程 生物医学工程
背景情况:
- 粘液过分分泌是导致呼吸道阻塞,炎症和喘中的肺功能减弱的重要因素.
- 了解粘液产生和清除的分子机制对于有效的喘管理至关重要.
研究的目的:
- 审查最近在喘中粘液过分分泌的病理生物学方面的进展.
- 讨论新兴的治疗策略来管理喘中的粘液相关并发症.
主要方法:
- 关于喘病理生物学和治疗的当前文献的综述.
- 分析了解粘素调节,粘液特性和炎症的进展情况.
- 对新型成像技术和治疗剂的评估.
主要成果:
- 了解细胞因子驱动的炎症 (例如,白蛋白-13) 和影响粘液的离子运输缺陷的进展.
- 开发先进的成像技术 (MDCT,高极化气体MRI) 来评估粘液堵塞.
- 新兴的疗法,包括针对T2炎症的生物药物和粘液溶解药物,显示出减少严重喘中的粘液的希望.
结论:
- 更好地了解粘液生物学和先进的成像/治疗方法可以提高喘管理.
- 针对粘液特征提供了减少气道阻塞和改善肺功能的潜力.
- 对粘液糖生物学的进一步研究对于开发新型治疗干预措施至关重要.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
211
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
211
Asthma: Pathogenesis and Management
314
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
314
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Drugs Used in Lower Respiratory Disorders: Overview
333
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
333


